Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The proteolipid protein gene

I R Griffiths1, P Montague, P Dickinson

  • 1Applied Neurobiology Group, University of Glasgow Veterinary School, UK.

Neuropathology and Applied Neurobiology
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

Distinct Phenotypes Associated with Increasing Dosage of the PLP Gene: Implications for CMT1A Due to PMP22 Gene Duplication.

Annals of the New York Academy of Sciences·2017
Same author

Evaluation of P16 expression in canine appendicular osteosarcoma.

BMC veterinary research·2017
Same author

Draft Genome Sequences of Six Different Staphylococcus epidermidis Clones, Isolated Individually from Preterm Neonates Presenting with Sepsis at Edinburgh's Royal Infirmary.

Genome announcements·2015
Same author

Draft Genome Sequence of a Pantoea sp. Isolated from a Preterm Neonatal Blood Sepsis Patient.

Genome announcements·2014
Same author

Draft Genome Sequence of a Staphylococcus aureus Isolate Taken from the Blood of a Preterm Neonatal Blood Sepsis Patient.

Genome announcements·2014
Same journal

Diagnostic Alteration Is Not Therapeutic Dependency: Lessons From Failed RET Inhibition in a PLAG-Altered CNS Embryonal Tumour.

Neuropathology and applied neurobiology·2026
Same journal

Respone to Škudar.

Neuropathology and applied neurobiology·2026
Same journal

Unravelling the Significance of Cystatin C and Bunina Bodies in Amyotrophic Lateral Sclerosis Pathogenesis.

Neuropathology and applied neurobiology·2026
Same journal

Neuropathological and Molecular Features Associated With a Heterozygous DNAJC7 Mutation in Amyotrophic Lateral Sclerosis.

Neuropathology and applied neurobiology·2026
Same journal

Central Nervous System Embryonal Tumour With PLAGL Amplification Lacking Typical Embryonal Morphology: Diagnostic Pitfall in a Paediatric Case.

Neuropathology and applied neurobiology·2026
Same journal

Lewy Bodies Are Not Associated With Neuronal or Synaptic Loss in Dementia With Lewy Bodies.

Neuropathology and applied neurobiology·2026
See all related articles

Proteolipid protein (PLP) and its isoform DM-20 are crucial for central nervous system (CNS) myelin structure. Mutations in the PLP gene cause dysmyelination disorders like Pelizaeus-Merzbacher disease (PMD) and X-linked spastic paraplegia (SPG2).

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Proteolipid protein (PLP) is the primary protein in central nervous system (CNS) myelin, essential for compact myelin structure.
  • An alternative splice variant, DM-20, is expressed earlier in CNS development and found in various cell types, including glial cells and cardiac myocytes.
  • PLP and DM-20 are hypothesized to function as membrane pores, supported by sequence similarities across species and within a potential PLP gene family.

Purpose of the Study:

  • To explore the structural and functional roles of Proteolipid Protein (PLP) and its isoform DM-20 in myelination.
  • To investigate the consequences of PLP gene mutations and dosage alterations on myelin development and integrity.
  • To compare the impact of PLP gene dosage in the CNS with peripheral myelin protein gene mutations in the peripheral nervous system (PNS).

Related Experiment Videos

Main Methods:

  • Analysis of molecular studies on the PLP gene family and sequence similarities.
  • Examination of phenotypes resulting from PLP gene mutations in various animal models.
  • Review of human genetic disorders associated with PLP gene mutations, including Pelizaeus-Merzbacher disease (PMD) and X-linked spastic paraplegia (SPG2).

Main Results:

  • PLP mutations lead to severe dysmyelination, abnormal myelin periodicity, reduced mature oligodendrocytes, and astrocytosis in animal models.
  • PLP gene duplication in transgenic animals and in certain PMD cases also results in dysmyelination.
  • X-linked spastic paraplegia (SPG2) is linked to PLP mutations with relatively normal DM-20 levels, contrasting with PMD phenotypes.

Conclusions:

  • The PLP gene plays a critical role in CNS myelination, with mutations causing significant neurological deficits.
  • Both mutations and altered gene dosage of PLP can lead to severe dysmyelination disorders.
  • The study highlights parallels between PLP gene dosage effects in the CNS and peripheral myelin protein-22 gene mutations in peripheral neuropathies like Charcot-Marie-Tooth disease.